Diagnosing MS: Recent guidelines and future goals focusing on magnetic resonance imaging

International MS Journal

Volumn 14, Issue 1, 2007, Pages 29-34

  Nielsen, Jessica M ^a   Korteweg, T ^a   Polman, C H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Guidelines; Magnetic resonance imaging; McDonald criteria; Multiple sclerosis

Indexed keywords

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE;

HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PRACTICE GUIDELINES;

EID: 34250315838     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-1438.
2. Wolinsky JS, PROMiSe Study Group. The diagnosis of primary progressive multiple sclerosis. J Neurol Sci 2003; 206: 145-152.
3. Schumacher GA, Beebe GW, Kibler RF, Kurland LT, Kurtzke JF, McDowell F et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-568.
4. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
5. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
6. Tintore M, Rovira A, Martinez MJ, Rio J, Diaz-Villoslada P, Brieva L et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000; 21: 702-706.
7. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
8. Dalton CM, Brex PA, Miszkiel KA, Hickman SJ, MacManus DG, Plant GT et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52: 47-53.
9. Tintoré M, Rovira A, Rio J, Nos C, Grive E, Sastre-Garriga J et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003; 60: 27-30.
10. Korteweg T, Tintore M, Uitdehaag B, Rovira A, Frederiksen J, Miller D et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006; 5: 221-227.
11. Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006; 67: 1242-1249.
12. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001; 357: 1576-1582.
13. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000; 343: 898-904.
14. Janssens AC, de Boer JB, Kalkers NF, Passchier J, van Doorn PA, Hintzen RQ. Patients with multiple sclerosis prefer early diagnosis. Eur J Neurol 2004; 11: 335-337.
15. Dalton CM, Brex PA, Miszkiel KA, Fernando K, MAcManus DG, Plant GT et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 2003; 53: 673-676.
16. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
17. Bot JC, Barkhof F, Nijeholt G, van Schaardenburg D, Voskuyl AE, Ader HJ et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002; 223: 46-56.
18. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V, Bergers E et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004; 62: 226-233.
19. Korteweg T, Barkhof F, Uitdehaag BM, Polman CH. How to use spinal cord magnetic resonance imaging in the McDonald diagnostic criteria for multiple sclerosis. Ann Neurol 2005; 57: 606-607.
20. Dalton CM, Brex PA, Miszkiel KA, Fernando K, MacManus DG, Plant GT et al. Spinal cord MRI in clinically isolated optic neuritis. J Neurol Neurosurg Psychiatry 2003; 74: 1577-1580.
21. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
22. Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; 61: 602-611.
23. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164.
24. Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003; 9: 260-274.
25. Miller DH, Filippi M, Fazekas F, Frederiksen JL, Matthews PM, Montalban X et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 2004; 56: 273-278.
26. Poser CM, Brinar VV. Problems with diagnostic criteria for multiple sclerosis. Lancet 2001; 358: 1746-1747.
27. Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BM, Polman CH. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 2005; 58: 781-783.
28. Uitdehaag BM, Kappos L, Bauer L, Freedman MS, Miller D, Sandbrink R et al. Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization. Mult Scler 2005; 11: 227-231.
29. Zipoli V, Portaccio E, Siracusa G, Pracucci G, Sorbi S, Amato MP. Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. Mult Scler 2003; 9: 481-485.
30. Korteweg T, Uitdehaag BM, Knol DL, Smithuis RH, Algra PR, de Vries C et al. Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis. Eur Radiol 2007; 17: 67-71.
31. Swanton JK, Fernando KT, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al. Modification of MRI criteria for MS in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006; 77: 830-833.